Replies to post #84491 on Cytodyn Inc (CYDY)

[Rockleo]

MWM.. Were these patients organ transplant recipients..?? Were most on Hemodialysis..?? Were ALL given no hope of recovery..?? Before the infusion..

If not.. Then you’re comparing apples to oranges.. When comparing them to the Montefiore patient’s treated with Leronlimab..

IMO..

[spiritof76]

That is a very positive abstract on a collection of case reviews. Can not wait to see the results of the phase 3 study on Lenzilumab. Should be completed in September 2020 with posting of findings in October of the same year. Please keep us all up to date on the progress.

Here is the link to the phase 3 study

https://clinicaltrials.gov/ct2/show/NCT04351152

[Trram]

You can't compare HGEN number to CYDY. The 4/10 patients survived, one improving with Leronlimab had other comorbidities such as kidney transplant, on ECMO, liver transplant, heart disease, etc.
The HGEN patients did not had those. So it's not the same comparison. Wait until the interim double blind data coming out from the severe/critical phase 3 CYDY study. That's the real comparison.

[ohm20]

None of the patients were even on mechanical ventilation hardly a comparable patient population.

All patients required oxygen supplementation at baseline; 1 patient was on non-invasive positive pressure ventilation, 8 (67%) were on low flow oxygen, 3 (25%) were on high flow oxygen.